SM
CELU icon

SG3 Management’s Celularity CELU Stock Holding History

SG3 Management’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-100
Closed -$1.29K – 47
2022
Q4 		$1.29K Sell
100
-400
-80% -$7.37K ﹤0.01% 206
2022
Q3 		$11.6K Sell
500
-1,100
-69% -$33.4K ﹤0.01% 267
2022
Q2 		$54K Buy
+1,600
New +$130K 0.01% 348
2021
Q2 		– Sell
-12,330
Closed -$1.24M – 1067
2021
Q1 		$1.24M Buy
+12,330
New +$1.26M 0.03% 540

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $716M AUM 21.09% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SG3 Management's CELU Position: Q2 2021 in Review

SG3 Management sold out of Celularity (CELU) in Q2 2021, closing a stake of 9,282 shares — an estimated $936K sold.

SG3 Management first reported a position in CELU in Q1 2021 and held it in 1 quarter. The position peaked at $936K in Q1 2021. 33 funds tracked by Wall St. Rank hold CELU as of Q2 2021.

  • SG3 Management reported no remaining Celularity position as of Q2 2021 after selling out during the quarter.
  • SG3 Management sold 9,282 Celularity shares in Q2 2021, an estimated $936K.
  • SG3 Management first reported a position in Celularity in Q1 2021 and held it in 1 quarter.
  • SG3 Management's Celularity position peaked at $936K in Q1 2021.
  • 33 funds tracked by Wall St. Rank held Celularity as of Q2 2021.

Based on SG3 Management's 13F filing for Q2 2021, filed 16 Aug 2021.